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Abstract
Children with rhinovirus-induced severe early wheezing have an increased risk of
developing asthma later in life. The exact molecular mechanisms for this association
are still mostly unknown. To identify potential changes in the transcriptional and
epigenetic regulation in rhinovirus-associated atopic or nonatopic asthma, we ana-
lyzed a cohort of 5-year-old children (n = 45) according to the virus etiology of the
first severe wheezing episode at the mean age of 13 months and to 5-year asthma
outcome. The development of atopic asthma in children with early rhinovirus-
induced wheezing was associated with DNA methylation changes at several geno-
mic sites in chromosomal regions previously linked to asthma. The strongest
changes in atopic asthma were detected in the promoter region of SMAD3 gene at
chr 15q22.33 and introns of DDO/METTL24 genes at 6q21. These changes were
validated to be present also at the average age of 8 years.
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1 | INTRODUCTION
Rhinovirus has been detected in 20%-40% of children with moder-
ate-to-severe wheezing episodes during the first 2 years of life.1-3
This etiology is of particular interest due to strong association with
recurrent wheezing, prolonged need of asthma controller medication,
doctor-diagnosed asthma up to 13 years of age4-10, and atopic
asthma at school age.11 The suggested explanations for this associa-
tion are low interferon responses (ie, impaired viral defense), early
airway inflammation (ie, broken epithelial barrier; T helper2-polarizedOsmala, Malonzo, L€ahdesm€aki, Lahesmaa and Jartti equally contributed to this study.
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immune responses) and genetic variations.12-16 Despite progress in
rhinovirus research, the exact molecular mechanisms for this associa-
tion are still mostly unknown.17 Furthermore, early predictive
biomarkers are needed for the identification of the rhinovirus-
infected children with an increased risk for developing asthma and
enabling design of effective intervention strategies to prevent
asthma.11,18 For these reasons, we examined epigenomic and tran-
scriptomic changes in 5-year-old children associated with the virus
etiology of their first wheezing episode and later asthma status.
2 | METHODS
The detailed study protocols are described in the Data S1.
2.1 | Clinical study protocol
The study protocol was approved by the Ethics Committee of the
Turku University Hospital and for the first 12 months was registered
at ClinicalTrials.gov (NCT00731575). At study entry, standard proce-
dures were carried out as previously described.19 The inclusion crite-
ria were age 3-23 months, delivery at ≥36 gestational weeks, first
wheezing episode and a written informed consent from a guardian.
Selected children were recruited to regular follow-up visits. Children
were diagnosed to have current asthma at the 4-year follow-up visit
if they met one or more of the subsequent criteria during the pre-
ceding 12 months: doctor-diagnosed asthma, regular use of doctor-
prescribed corticosteroid asthma therapy, use of oral corticosteroids
for asthma exacerbations, acute asthma attack relieved by repeated
use of bronchodilator.20 Current atopic asthma was defined as
asthma with laboratory-verified sensitization (IgE antibodies
>0.35 kU/L) at the 4-year follow-up visit. Nonatopic asthma was
defined as asthma without these. The statistical analysis is described
in Data S1.
2.2 | Epigenome and transcriptome analysis
Total RNA (Tempus Spin RNA Isolation kit) and DNA (Qiagen’s
QIAamp DNA Blood Maxi kit) were isolated from whole blood. The
messenger RNA-seq samples were prepared with Illumina TruSeq
RNA Sample Preparation kit v2. The reduced representation bisulfite
sequencing (RRBS) libraries were prepared with a protocol adapted
from Boyle et al.21,22 For genomic localization of promoters and
enhancers H3K4me1, H3K4me3 and H3K27Ac ChIP-seq was carried
out from peripheral blood mononuclear cells isolated from 2 refer-
ence individuals. Briefly, the chromatin was prepared (truChIP Low
Cell Chromatin Kit, Covaris) and ChIP reactions (Auto Histone ChIP-
seq kit) were carried out with Diagenode IP-Star SX 8G robot. The
libraries were sequenced with Illumina HiSeq2000 platform. The raw
data were quality controlled with FastQC23 and other tools
described in the Data S1. The RNA-seq data were analyzed with
RNA Express v1.0.0 in Illumina BaseSpace cloud.24-26 The RRBS data
were filtered with Trim Galore! v0.3.3,27 and reads were aligned to
human genome hg19 with bismark v0.12.528 and bowtie2 v2.2.3.29
The methylation calls were extracted with Bismark. Outliers (eg,
RnBeads MDS and PCA30) were excluded from the analysis. Differ-
entially methylated regions were identified with RADMeth.31,32 The
ChIP-seq data were analyzed in Illumina BaseSpace Cloud with ChIP-
Seq BaseSpace Labs tool. In addition, ENCODE ChIP-seq data on
H3K4me1, H3K4me3, H3K27me3, and H3K9me3 from PBMCs were
utilized in the analysis to examine colocalization of DNA methylation
changes with histone marks.33-35
2.3 | Targeted pyrosequencing
The oligos were designed with Pyromark Software Assay Design 2.0.
Samples were prepared, and pyrosequencing was carried out with
Qiagen’s Pyromark Q24 according to the manufacturer’s instructions.
The data were analyzed with Pyromark Advanced Software.
Unpaired t test was used to calculate the statistical differences
between study groups. See the Data S1 for more details.
3 | RESULTS
3.1 | Patient characteristics
Originally, 124 first-time wheezing children were enrolled of whom
77 (62%) children participated in the 4-year follow-up visit
(Table S1). Of these, 48 most representative children were selected
for the transcriptome and epigenome studies according to the virus
etiology of their first severe wheezing episode, and their 5-year
asthma outcome as follows: rhinovirus + asthma + (n = 16), rhi-
novirus + asthma  (n = 16), and rhinovirus  asthma  (n = 16).
Three study subjects from the latter group were excluded after qual-
ity analysis. Further details of patient characteristics are shown in
Tables S2 and S3.
3.2 | DNA methylome and transcriptome changes
in rhinovirus-associated wheezing and asthma
Comparison of the children with rhinovirus + atopic
asthma + (n = 11) vs rhinovirus + asthma  (n = 16) revealed
methylation changes (median change 20% and FDR ≤0.05) in 17
genomic regions associated with atopic asthma (Table 1). The stron-
gest changes were observed in the region chr6:110720838-
110720871 located in the introns of genes D-aspartate oxidase
(DDO) and methyltransferase like 24 (METTL24), and region
chr15:67356671-67356696 located 1511 bp upstream of the tran-
scription start site of SMAD family member 3 (SMAD3) gene, close
to active promoter mark (H3K4me3). Similarly, comparison of the
children with rhinovirus + nonatopic asthma + (n = 5) vs rhi-
novirus + asthma  (n = 10) revealed differences in 13 genomic
regions (Table 1). The strongest change associated with nonatopic
asthma was observed in the site chr9:139860386-139860387 over-
lapping enhancer mark H3K4me1, 9.12 kb upstream of the gene
prostaglandin D2 synthase (PTGDS).
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Interestingly, no differences in gene expression (fold change cut
off 1.4, FDR ≤0.05) were observed to be associated with either
atopic or nonatopic asthma at the time of sampling, although for
example SMAD3 gene was detected to be expressed in the blood of
the study subjects.
3.3 | Targeted validation and stability of the DNA
methylation changes
The CpG methylation changes associated with atopic asthma at the
DDO/METTL24 intron (chr6:110720839-110720905) and SMAD3
promoter (chr15:67356631-67356721) with RRBS (Table 1) were
confirmed with targeted pyrosequencing of the samples collected at
the average age of 5 years (Figure 1A, Figure S1). Importantly, analy-
sis of the samples collected from the same children at the average
age of 8 years revealed that the methylation changes associated
with atopic asthma in these 2 regions were still present 3 years later
(P ≤ 5.08E-04; Figure 1B).
4 | DISCUSSION
We detected epigenetic changes in several genomic regions in
children who had suffered early rhinovirus-induced wheezing, and
which associated with later onset of asthma. Interestingly, among
the strongest changes associated with atopic asthma was DNA
TABLE 1 The differentially methylated genomic regions associated with rhinovirus-induced wheezing and asthma (median methylation
difference ≥20, FDR ≤0.05)
Genomic location (hg19) No. of sites Median meDiff (%) Genomic element Chromatin marks (1 kb) Closest gene (Symbol)
Differentially methylated genomic regions associated with atopic asthma
chr15:67356671-67356696 2 41.68 Intergenic H3K4me1, -me3 SMAD3
chr10:116273998-116274013 2 33.70 Intronic H3K4me1 ABLIM1
chr2:158287048-158287070 2 29.13 Intronic H3K4me1a CYTIP
chr7:73456938-73456960 4 28.34 Exon-intron – ELN
chr13:110384309-110384326 4 28.07 Intergenic H3K4me3a LINC00676, IRS2
chr7:35302562-35302563 1 27.40 Intergenic H3K27me3a TBX20
chr2:31806387-31806402 2 25.17 Intergenic H3K27me3 SRD5A2
chr16:89674059-89674095 3 23.19 Intergenic – DPEP1
chr17:80542056-80542086 3 21.92 Exon-intron – FOXK2
chr19:9711129-9711155 2 21.65 Intergenic – ZNF561
chr7:66211672-66211673 1 21.28 Intronic H3K4me1a RABGEF1
chr7:1005102-1005133 5 21.24 Exon, intron H3K4me1a COX19, ADAP1
chr14:106437030-106437045 2 20.36 Exon-intron – abParts, ADAM6
chr11:123388388-123388389 1 20.64 Intergenic – GRAMD1B
chr1:143279717-143279732 2 20.98 Intronic – CR936796
chr6:29831764-29831935 4 24.13 Intronic – HLA-G, HLA-H
chr6:110720838-110720871 3 48.19 Intronic H3K4me3 DDO, METTL24
Differentially methylated genomic regions associated with nonatopic asthma
chr9:139860386-139860387 1 45.95 Intergenic H3K4me1a PTGDS
chr6:144329349-144329433 4 35.90 Intron, exon H3K4me1, -me3a PLAGL1
chr1:3292550-3292562 2 34.38 Intron – PRDM16
chr19:2546695-2546719 6 32.88 Intron – GNG7
chr7:138726331-138726332 1 26.95 Intergenic – ZC3HAV1
chr7:48241582-48241586 2 24.72 Intron – ABCA13
chr6:169977857-169977884 3 24.09 Intron – WDR27
chr11:67051767-67051780 2 23.21 Exon H3K4me1a, -me3a ADRBK1
chr18:77906226-77906417 4 22.51 Intron H3K4me1a, -me3a PARD6G-AS1
chr6:20320057-20320136 4 20.95 Intergenic H3K4me1, -me3a E2F3
chr9:45439874-45439891 3 23.22 Intergenic H3K4me1, -me3 LOC102723709
chr4:3572886-3572887 1 33.30 Intergenic – LINC00955
chr4:49150172-49150193 4 34.46 Intergenic H3K4me1, -me3, H3K27me3 CWH43
aDifferentially methylated region overlaps with the histone mark.
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methylation alteration in the promoter of SMAD3 gene in a well-
known asthma locus at chr 15q22.33.36 SMAD3 protein has an
important function in the regulation of immune responses and
together with the other components of the transforming growth
factor beta (TGFb) signaling regulate fibrosis in airways.37 While
our study was in progress, DeVries et al38 reported that hyperme-
thylation of SMAD3 promoter is associated with asthma of children
of asthmatic mothers further confirming importance of this epige-
netic change in the molecular pathology of asthma. In addition, we
detected changes in DDO/METTL24 genes at 6q21 and in HLA
locus at chr 6p21.1-22.3 previously associated with asthma.39
HLA-G gene, 33 kb upstream from the differentially methylated
region, is an asthma susceptibility gene,40 and its expression is
induced by allergens.41 Several other differentially methylated sites
were also in the proximity of genes, such as ELN42 or CYTIP,43,44
previously linked to lung or immune cell functions, or viral
infections, therefore having potential functional significance in the
atopic asthma.
Among the strongest changes associated with nonatopic asthma
was DNA methylation change linked to PTGDS gene. PTGDS
F IGURE 1 Validation and stability of
the DNA methylation changes associated
with atopic asthma. The strongest DNA
methylation changes associated with atopic
asthma (rhinovirus + atopic asthma + vs
rhinovirus + atopic asthma ) were
validated with targeted pyrosequencing (A)
at the average age of 5 y and (B) at the
average age of 8 y in samples collected
from the same children. In addition, to
outlier box plots, the distribution of DNA
methylation levels of individual CpG sites
within the indicated region for each
individual is shown in the figure. In
addition, median methylation differences
and t test P-values are shown in the figure
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catalyzes synthesis of prostaglandin D2, which mediates develop-
ment and symptoms of asthma by recruiting Th2 cells and inducing
contraction of airways smooth muscle cells.45,46 Prostaglandin D2
enhances proinflammatory actions of macrophages and subsequent
neutrophil activation.47 Therefore, altered regulation of PTGDS may
be important in the development of nonatopic asthma.
In conclusion, our results demonstrate that epigenetic changes
associated with rhinovirus-induced early wheezing and asthma can
be detected in peripheral blood. The strongest changes associated
with atopic asthma were localized in the genomic regions previously
associated with asthma15,16,36 and importantly for SMAD3 promoter
and in DDO/METTL24 gene were detected at the age of both 5 and
8 years. Although we did not detect significant changes in the tran-
scriptomes at the time of measurement, it is possible that the regula-
tion of the affected genes is altered, for example in response to
antigen challenge. Alternatively, the DNA methylation changes
detected in blood reflect functional changes present in other tissues,
such as airways.
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